Atopic Dermatitis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Key driver of atopic dermatitis discovered: Finding provides a novel ... - Science Daily



Science Daily
 
Key driver of atopic dermatitis discovered: Finding provides a novel ... 
Science Daily
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In a new study, researchers reveal an important player that promotes skin inflammation in atopic dermatitis and the ...

and more » 


Key Driver of Atopic Dermatitis Discovered - Scicasts (press release) (blog)



Scicasts (press release) (blog)
 
Key Driver of Atopic Dermatitis Discovered 
Scicasts (press release) (blog)
La Jolla, CA (Scicasts) ? Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that ...

and more » 


Atopic Dermatitis: Skin Microbiome Altered in Lesional and Non-Lesional Skin - MedicalResearch.com (blog)



MedicalResearch.com (blog)
 
Atopic Dermatitis: Skin Microbiome Altered in Lesional and Non-Lesional Skin 
MedicalResearch.com (blog)
Response: ?The human microbiome seems to play an important role in health and disease, by influencing host cells and contributing to host immunity. A balanced interplay between host cells and resident bacteria is important, and dysbiosis is linked to ...

 


FDA Grants Upadacitinib Breakthrough Therapy for Atopic Dermatitis - Specialty Pharmacy Times



FDA Grants Upadacitinib Breakthrough Therapy for Atopic Dermatitis 
Specialty Pharmacy Times
AbbVie today announced that the FDA granted breakthrough therapy designation to upadacitinib for adults with moderate-to-severe atopic dermatitis, according to a press release. Upadacitinib is an investigational JAK1-selective inhibitor that ...
AbbVie (ABBV) Says Upadacitinib Granted Breakthrough Therapy Designation FDA for Atopic Dermatitis StreetInsider.com
AbbVie's Upadacitinib Granted Breakthrough Therapy by FDA MD Magazine

all 3 news articles » 


New Atopic Dermatitis Yardstick provides practical guidance and management insights - EurekAlert (press release)



New Atopic Dermatitis Yardstick provides practical guidance and management insights 
EurekAlert (press release)
ARLINGTON HEIGHTS, IL (January 4, 2018) - Patients with atopic dermatitis (AD) - also known as eczema - often face a tough, uphill battle for treatment. Symptoms include severe itching, scaly rashes, extreme dry skin and inflammation. Those who suffer ...

and more » 


Study Quantifies Burden of Atopic Dermatitis on Patients - AJMC.com Managed Markets Network



AJMC.com Managed Markets Network
 
Study Quantifies Burden of Atopic Dermatitis on Patients 
AJMC.com Managed Markets Network
Patients with atopic dermatitis (AD) have a significantly greater risk for additional atopic diseases, as well as significantly greater healthcare resource utilization and total cost compared with adults without AD. The burden of AD was generally ...

 


FDA Grants AbbVie's Upadacitinib Breakthrough Therapy Designation for Atopic Dermatitis - Drug Discovery & Development



Drug Discovery & Development
 
FDA Grants AbbVie's Upadacitinib Breakthrough Therapy Designation for Atopic Dermatitis 
Drug Discovery & Development
AbbVie announced the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for the investigational, once-daily oral JAK1-selective inhibitor upadacitinib (ABT-494) in adult patients with moderate to severe atopic dermatitis ...
Upadacitinib receives breakthrough therapy designation for atopic dermatitis European Pharmaceutical Review
BRIEF?Breakthrough status for upadacitinib in atopic dermatitis The Pharma Letter
AbbVie's JAK1 Inhibitor Granted FDA's Breakthrough Therapy GuruFocus.com

all 5 news articles » 


Fundamental Causal Agent of Atopic Dermatitis Identified - The Global Health News (press release) (blog)



The Global Health News (press release) (blog)
 
Fundamental Causal Agent of Atopic Dermatitis Identified 
The Global Health News (press release) (blog)
Atopic dermatitis is otherwise called atopic skin inflammation, is a perpetual pruritic fiery skin condition that is driven by an unfavorably susceptible response. It brings about irritated, red, swollen, and split skin. Analysts from the La Jolla ...

 


Andrew Alexis, MD, MPH: The State of Atopic Dermatitis - MD Magazine



MD Magazine
 
Andrew Alexis, MD, MPH: The State of Atopic Dermatitis 
MD Magazine
The second big advancement is dupilumab, which is an injectable biologic agent for atopic dermatitis. Now this one is approved for moderate to severe atopic dermatitis, that we're talking about, [but] a more severe population than the topical that I ...

 


Scientists find how potential new eczema treatment could also alleviate asthma - News-Medical.net



Scientists find how potential new eczema treatment could also alleviate asthma 
News-Medical.net
Scientists from VIB-UGent have discovered insights for a possible new therapy for eczema that also reduces the severity of asthma. The findings are an important next step in understanding the relationship between the two inflammatory diseases and to ...

and more »